Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
2006 | 1 |
2011 | 1 |
2013 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.
Br J Clin Pharmacol. 2013 May;75(5):1289-98. doi: 10.1111/j.1365-2125.2012.04477.x.
Br J Clin Pharmacol. 2013.
PMID: 23043368
Free PMC article.
Clinical Trial.
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
Szepietowski JC, Nilganuwong S, Wozniacka A, Kuhn A, Nyberg F, van Vollenhoven RF, Bengtsson AA, Reich A, de Vries DE, van Hartingsveldt B, Robinson DW Jr, Gordon R, Hsu B.
Szepietowski JC, et al. Among authors: van hartingsveldt b.
Arthritis Rheum. 2013 Oct;65(10):2661-71. doi: 10.1002/art.38091.
Arthritis Rheum. 2013.
PMID: 23896980
Free article.
Clinical Trial.
Item in Clipboard
Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.
Xu Z, Bouman-Thio E, Comisar C, Frederick B, Van Hartingsveldt B, Marini JC, Davis HM, Zhou H.
Xu Z, et al. Among authors: van hartingsveldt b.
Br J Clin Pharmacol. 2011 Aug;72(2):270-81. doi: 10.1111/j.1365-2125.2011.03964.x.
Br J Clin Pharmacol. 2011.
PMID: 21392075
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
Westhovens R, Houssiau F, Joly J, Everitt DE, Zhu Y, Sisco D, Van Hartingsveldt B, Mascelli MA, Graham MA, Durez P, Bouman-Thio E.
Westhovens R, et al. Among authors: van hartingsveldt b.
J Rheumatol. 2006 May;33(5):847-53. Epub 2006 Apr 1.
J Rheumatol. 2006.
PMID: 16583466
Clinical Trial.
Item in Clipboard
Ex vivo cytokine release from whole blood. A routine method for health effect screening.
Schins RP, van Hartingsveldt B, Borm PJ.
Schins RP, et al. Among authors: van hartingsveldt b.
Exp Toxicol Pathol. 1996 Nov;48(6):494-6. doi: 10.1016/S0940-2993(96)80064-9.
Exp Toxicol Pathol. 1996.
PMID: 8954330
No abstract available.
Item in Clipboard
Cite
Cite